✦ LIBER ✦

77* Phase III Study [CF-302] of inhaled dry powder mannitol (Bronchitol(tm)) in cystic fibrosis – results from the 6 month open label phase

✍ Scribed by M. Aitken; P.A. Flume; D.E. Geller; A. Lapey; J. Zuckerman; K. De Boeck; G. Bellon; H. Hebestreit; E. Haarman; H. Fox; B. Charlton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III study of inhaled dry powder ma

✍ D. Bilton; P. Robinson; P. Cooper; J. Kolbe; C.G. Gallagher; H. Fox; B. Charlton 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Randomised, double blind, placebo-contro

✍ D. Bilton; P. Robinson; P. Cooper; B. Charlton 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

78 Combined data from two phase III stud

✍ D. Bilton; M. Aitken; P.A. Flume; D.E. Geller; A. Lapey; J. Zuckerman; K. De Boe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB

79 Inhaled dry powder mannitol in cystic

✍ D. Bilton; M. Aitken; H. Fox; B. Charlton 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

WS5.2 Inhaled dry powder mannitol in cys

✍ D. Bilton; M. Aitken; K. De Boeck; H. Fox; B. Charlton 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB